TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from XBiotech ( (XBIT) ) is now available.
On October 2, 2025, XBiotech, Inc. entered into a new Executive Employment Agreement with John Simard, effective from October 1, 2025, to replace previous agreements. The agreement, approved by the Compensation Committee, formalizes Mr. Simard’s compensation trends and acknowledges his contributions and leadership, ensuring a smooth transition in case of his departure or retirement. Mr. Simard’s annual base salary is set at $1,250,000, with an annual base bonus of $4,530,442, subject to adjustments and committee discretion for additional compensation. The agreement also outlines severance terms and continued consulting roles post-retirement.
More about XBiotech
Average Trading Volume: 50,459
Technical Sentiment Signal: Sell
Current Market Cap: $80.49M
See more data about XBIT stock on TipRanks’ Stock Analysis page.